EWTX
Edgewise Therapeutics, Inc. · Healthcare
General Counsel John R Moore sold $80K of Edgewise Therapeutics, Inc.
Sold$80,146
$7.42Price
10,800Shares
−78%Stake
What EWTX did after the filing
- The stock from Wed, May 18 close, $7.26
- +11.3%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Jul 1 close.
Traded Mon, May 16. Filed Wed, May 18, 1:15 PM ET, during the session. Returns use the May 18 close and the Jul 1 close. Not investment advice.